New Jersey Weight Loss Doctor
Forever Young, where your journey to sustainable weight management is guided by our expert weight loss doctor in New Jersey. As a premier prescription weight loss clinic, we are dedicated to providing you with personalized and effective weight loss solutions tailored to your individual health needs and goals.
Medical Weight Loss Prescription Program
Our clinic specializes in advanced prescription weight loss programs, each designed by our experienced weight loss specialists to maximize your results safely and sustainably. We understand that each patient’s path to weight loss is unique, which is why we offer:
- Personalized Medication Plans: Tailored specifically for your body’s needs to enhance weight loss effectively.
- Nutritional Counseling: Expert guidance to help you make healthy eating choices that support your weight loss goals.
- Behavioral Support: Strategies to help you adopt and maintain lifestyle changes necessary for long-term success.
- Regular Monitoring and Adjustments: Continuous oversight by our weight loss doctor to ensure optimal progress and adjust treatments as needed.
Consult Our Weight Loss Specialist in New Jersey
At our prescription weight loss clinic in New Jersey, you will receive care from our team of dedicated medical weight loss doctors. We are excited to offer cutting-edge treatments such as Mounjaro, a new medication that has shown significant promise in aiding weight loss. Under the supervision of our weight loss specialists, you can explore how Mounjaro and other advanced treatments can be integrated into your personalized weight loss plan.
Introducing Mounjaro: A Revolutionary Weight Loss Treatment
Mounjaro (tirzepatide) is a groundbreaking treatment option now available at Forever Young. It’s designed for individuals looking for significant weight loss and management solutions. Mounjaro works by mimicking certain hormones that target areas of the brain involved in appetite regulation, leading to reduced hunger and increased feelings of fullness. This medication is particularly effective when combined with a comprehensive weight management program, including diet modification and regular physical activity, overseen by our medical professionals.
The Forever Slim Prescription Weight Loss Program
NO SPECIAL DIETS. NO DIFFICULT WORKOUTS. JUST RESULTS.
Weight loss can be challenging, and sometimes eating right and exercising may not be enough, especially as we age. That’s where our Forever Slim Program comes into play, utilizing GLP-1 Agonists not only for diabetes management but also for effective weight loss in adults with certain BMI thresholds. Just a simple weekly injection can lead to substantial weight loss:
- Up to 25 pounds in 3 months.
- Up to 50 pounds or more in 5 months.
You can repeat this program as needed, and results can vary among patients but are enhanced with a healthy lifestyle and physician recommendations.
Program Schedule and Structure:
- Weekly Clinic Visits: Quick 15-minute appointments for injections, with continuous assessment and dose adjustments.
- Optional Monthly Visits: For patients comfortable with self-injecting at home, monthly check-ins are also available.
Please Note: We do not participate in any insurance programs, ensuring direct and comprehensive care.
By choosing Forever Young, you are not just getting a weight loss doctor; you are partnering with a team of medical professionals committed to your health and well-being. Our holistic approach ensures that you receive the comprehensive support you need to achieve and maintain your ideal weight.
Start Your Journey with a Trusted NJ Weight Loss Doctor
Ready to transform your life with the help of a professional weight loss doctor in New Jersey? Visit Forever Young, your dedicated prescription weight loss clinic, and discover how our tailored programs and innovative treatments like Mounjaro can help you achieve the results you desire. Book your consultation today and take the first step towards a healthier, more vibrant you.
Frequently Asked Questions
GLP-1 Agonists are an injectable medicine that helps type 2 diabetics control their blood sugar when combined with diet and exercise. Glucagon-like peptide-1 (GLP-1) agonists work by simulating the hormone GLP-1 in your body to lower blood sugar levels after a meal.
GLP-1 (glucagon-like peptide 1) is a hormone that stimulates glucose-dependent insulin production and has a significant impact on blood sugar management. Insulin is a hormone that encourages the uptake of sugar by cells, stores sugar as glycogen, stimulates fat storage, and instructs the body to create skeletal muscle. GLP-1 also suppresses glucagon release (which delays the release of sugar into the bloodstream, causing you to burn more fat), slows stomach emptying (which makes you feel full), and reduces the desire to eat (because you feel full).
GLP-1 Agonist is not an insulin replacement or a form of insulin. When glucose (sugar) is present, GLP-1 Agonist stimulates your pancreas to release insulin. GLP-1 Agonist isn’t utilized when your pancreas can’t create insulin, such as in type 1 diabetes patients, because it relies on your body’s own insulin to have this effect.
GLP-1 Agonist isn’t a stimulant at all. GLP-1 Agonist works differently than other weight reduction drugs like phentermine, which have stimulating effects that help you lose weight (see above).
GLP-1 agonists help you lose weight while also helping you control your blood sugar. The main hormone involved is GLP-1, which slows down the rate at which food is discharged from your stomach (called gastric emptying). In addition to allowing your pancreas to release insulin, the GLP-1 agonist suppresses a hormone that stimulates your liver to release sugar (glucagon). When these processes work together, you’ll feel less hungry, which will allow you to eat less and lose more weight.
Yes, it is thought that GLP-1 Agonist can help you lose weight. GLP-1 plays a direct influence in how your appetite is regulated, in addition to slowing gastric emptying to make you feel fuller for longer.
With GLP-1 Agonist, you’ll gradually increase to the target dose, at which point you’ll notice the biggest weight loss. This was the situation in the clinical studies, where participants’ doses were gradually increased until they reached a weekly dose of 2.4 mg. Most participants were able to attain the full dose in the phase 3 trial, which examined outcomes at 20 weeks, and they also lost weight as their dose was increased. At the full dose, they lost even more weight over the next 48 weeks. It’s crucial to remember that weight loss takes time, and the best benefits come from combining your medicine with a good diet and regular exercise. Sometimes the medication may not work for you, or you may not be able to tolerate the full dose due to side effects.
GLP-1 Agonist is currently licensed by the FDA solely to help with blood sugar control in patients with type 2 diabetes and to reduce the risk of significant cardiovascular events (such as heart attack and stroke) in people who have both type 2 diabetes and heart disease. If you’re using GLP-1 Agonist for either of these reasons, you’ll follow your healthcare provider’s instructions because you’re managing a chronic ailment. If you don’t have type 2 diabetes and want to test GLP-1 Agonist to help you lose weight, we’ll know more about long-term safety once the FDA examines the evidence for this new indication. What we do know is that study participants received treatment for a period of 68 weeks (about 1.5 years) during each of the four trials conducted by the company.
Yes. When taken as directed, GLP-1 Agonist is deemed safe and effective. However, just because something is safe does not mean it is without risk. GLP-1 Agonist also comes with a boxed warning about thyroid C-cell tumors in rats (with uncertain risk in humans), and it shouldn’t be used if you or someone in your family has had thyroid cancer. People with type 1 diabetes with a history of pancreatitis should avoid taking GLP-1 Agonist. People who are using other blood sugar-lowering drugs should use GLP-1 Agonist with caution.
The amount being investigated for weight reduction is 2.4 mg once weekly, which is higher than the levels currently approved for diabetes. Furthermore, GLP-1 Agonist is being investigated in a separate group of people: those with a BMI of greater than or equal to 30 kg/m2 alone or 27 kg/m2 with at least one weight-related comorbidities (diabetes excluded).
No. For persons who do not have type 2 diabetes, GLP-1 Agonist is not covered by insurance. However, as part of our GLP-1 Agonist Weight Loss Program, you may be able to obtain this drug.
Every week, all patients are given the GLP-1 Agonist – injected subcutaneously into belly fat. All patients get a weekly dose increase depending on patient comfort and weight loss goals.
If you’re using a GLP-1 Agonist, there are a few things to keep in mind.
To begin, you should minimize your alcohol consumption while taking GLP-1 Agonist, especially if you have diabetes. Alcohol has an effect on your blood sugar, and when combined with GLP-1 Agonist, there’s a chance it’ll drop too low, especially if you’re drinking on an empty stomach. It’s also possible that alcohol will irritate your stomach. When combined with any of the medication’s GI adverse effects, this could make you feel much worse.
If you’re taking any oral drugs, you’ll want to be cautious. Because GLP-1 Agonist reduces stomach emptying, it may have an impact on how much oral medication your body absorbs. And while trials haven’t shown this to be significant with GLP-1 Agonist, you’ll want to make sure your provider is aware of any other medications you are taking before starting GLP-1 Agonist.
The following are some of the most prevalent GLP-1 Agonist adverse effects:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Constipation
Rarely, but it can happen. GLP-1 Agonists have the potential to induce major adverse effects, including as:
- Vomiting for a long time Patients taking GLP-1 Agonist may develop gastroparesis, a condition in which the stomach stops moving and the patient vomits a lot. Dehydration and electrolyte abnormalities can result as a result of this. If you have vomiting that lasts more than a day, stop taking GLP-1 Agonist and contact your doctor right once.
- Your pancreas is inflamed (pancreatitis). If you get severe stomach pain (abdomen) that won’t go away, with or without vomiting, stop taking GLP-1 Agonist and contact your doctor right once. The pain may radiate from your abdomen to your back.
- Visional shifts. If you notice changes in your vision while taking GLP-1 Agonist, tell your doctor.
- Blood sugar levels are low (hypoglycemia). If you use GLP-1 Agonist with another prescription that might cause low blood sugar, such as a sulfonylurea or insulin, your chances of experiencing low blood sugar are increased. Dizziness or lightheadedness, blurred vision, anxiety, irritability, or mood changes, sweating, slurred speech, hunger, disorientation or drowsiness, shakiness, weakness, headache, fast heartbeat, and feeling jittery are all signs and symptoms of low blood sugar.
- Problems with the kidneys (kidney failure). Diarrhea, nausea, and vomiting in persons with renal difficulties can lead to a loss of fluids (dehydration), which can exacerbate kidney problems. It’s critical that you drink plenty of water to avoid becoming dehydrated.
- Allergic reactions that are severe. If you have any symptoms of a significant allergic reaction, such as swelling of your face, lips, tongue, or throat; difficulty breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or a very rapid heartbeat, stop using GLP-1 Agonist and get medical attention right once.
